KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $231.9 million.

  • Exact Sciences' Cash from Financing Activities fell 577.88% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.7 million, marking a year-over-year decrease of 208.77%. This contributed to the annual value of $231.9 million for FY2024, which is 45.13% up from last year.
  • Per Exact Sciences' latest filing, its Cash from Financing Activities stood at $231.9 million for FY2024, which was up 45.13% from $159.8 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Cash from Financing Activities registered a high of $1.9 billion during FY2020, and its lowest value of $8.5 million during FY2021.
  • Its 3-year average for Cash from Financing Activities is $156.0 million, with a median of $159.8 million in 2023.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 99.55% in 2021, then skyrocketed by 802.80% in 2022.
  • Over the past 5 years, Exact Sciences' Cash from Financing Activities (Yearly) stood at $1.9 billion in 2020, then slumped by 99.55% to $8.5 million in 2021, then spiked by 802.80% to $76.5 million in 2022, then spiked by 108.89% to $159.8 million in 2023, then spiked by 45.13% to $231.9 million in 2024.